Loading…

Is the serum oxytocin level altered by treatment in rheumatoid arthritis patients complicated with depression?

The objective of this study was to investigate the factors associated with depression, including serum oxytocin (OXT) levels, disease activity, activities of daily living (ADL), and quality of life (QOL), and their effects on rheumatoid arthritis (RA). This study included 42 RA patients who received...

Full description

Saved in:
Bibliographic Details
Published in:European journal of rheumatology 2018-03, Vol.5 (1), p.22-26
Main Authors: Miwa, Yusuke, Furuya, Hidekazu, Yanai, Ryo, Kasama, Tsuyoshi, Sanada, Kenji
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 26
container_issue 1
container_start_page 22
container_title European journal of rheumatology
container_volume 5
creator Miwa, Yusuke
Furuya, Hidekazu
Yanai, Ryo
Kasama, Tsuyoshi
Sanada, Kenji
description The objective of this study was to investigate the factors associated with depression, including serum oxytocin (OXT) levels, disease activity, activities of daily living (ADL), and quality of life (QOL), and their effects on rheumatoid arthritis (RA). This study included 42 RA patients who received treatment with a biological agent. We measured the following variables before and after 6 months of treatment: baseline characteristics, including age, sex, disease duration, smoking, and body mass index (BMI); prednisolone and methotrexate dose; serum level of matrix metalloproteinase-3 (MMP-3); erythrocyte sedimentation rate (ESR); and C-reactive protein (CRP) level. The disease activity of RA was assessed using the Simplified Disease Activity Index (SDAI); depression was assessed using the Hamilton Depression Rating Scale (HAM-D); ADL was assessed using the Health Assessment Questionnaire; and QOL was assessed using the Short Form (SF)-36. Serum OXT levels were determined using enzyme-linked immunosorbent assay. The HAM-D score significantly correlated with the SDAI, and the mental component summary (MCS) score of SF-36. However, the serum OXT levels did not correlate with the HAM-D score. Regression analysis using the HAM-D score as the objective variable identified female sex, smoking, BMI, and all the three component scores of SF-36, but not serum OXT levels, as significant factors. Comparisons between before and after treatment showed that the HAM-D score improved from 5 to 1.5; however, the serum OXT levels did not change. The variables of female sex, smoking, BMI, and QOL correlated with depression complicated with RA. However, serum OXT levels did not correlate directly.
doi_str_mv 10.5152/eurjrheum.2018.17021
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5895146</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A559690600</galeid><sourcerecordid>A559690600</sourcerecordid><originalsourceid>FETCH-LOGICAL-c354t-ac159eeb5f265f4f66e11a2dab1dd33fbf170fa07aceaef9bc8152094c6317353</originalsourceid><addsrcrecordid>eNptUstu3CAURVWrJkryB1GF1E03ngI2xmxaRVEfkSJl06wRxpeYCBsXcNr5-zIz6aiRKhYgzuPeCwehS0o2nHL2Edb4GEdYpw0jtNtQQRh9hU4ZbbqqYUK-3p9FJQUjJ-gipUdCCBWMSSreohMmWy46QU7RfJNwHgEniOuEw-9tDsbN2MMTeKx9hggD7rc4R9B5gjnjgu4r6xzcgHXMY3TZJbzo7AqesAnT4p3RuSh_uTziAZYIKbkwfz5Hb6z2CS6e9zN0__XLj-vv1e3dt5vrq9vK1LzJlTaUS4CeW9Zy29i2BUo1G3RPh6GubW_LxFYToQ1osLI3XXkVIhvT1lTUvD5Dnw6-y9pPMJjSWNReLdFNOm5V0E69RGY3qofwpHgnOW3aYvDh2SCGnyukrCaXDHivZwhrUoww3pGG7KnvD9QH7UG52YbiaHZ0dcW5bCVpCSmszX9YZQ0wORNmsK7cvxA0B4GJIaUI9tg9JWoXAnUMgdqFQO1DUGTv_p38KPr75fUfGp-zKg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2025804046</pqid></control><display><type>article</type><title>Is the serum oxytocin level altered by treatment in rheumatoid arthritis patients complicated with depression?</title><source>PubMed Central</source><creator>Miwa, Yusuke ; Furuya, Hidekazu ; Yanai, Ryo ; Kasama, Tsuyoshi ; Sanada, Kenji</creator><creatorcontrib>Miwa, Yusuke ; Furuya, Hidekazu ; Yanai, Ryo ; Kasama, Tsuyoshi ; Sanada, Kenji</creatorcontrib><description>The objective of this study was to investigate the factors associated with depression, including serum oxytocin (OXT) levels, disease activity, activities of daily living (ADL), and quality of life (QOL), and their effects on rheumatoid arthritis (RA). This study included 42 RA patients who received treatment with a biological agent. We measured the following variables before and after 6 months of treatment: baseline characteristics, including age, sex, disease duration, smoking, and body mass index (BMI); prednisolone and methotrexate dose; serum level of matrix metalloproteinase-3 (MMP-3); erythrocyte sedimentation rate (ESR); and C-reactive protein (CRP) level. The disease activity of RA was assessed using the Simplified Disease Activity Index (SDAI); depression was assessed using the Hamilton Depression Rating Scale (HAM-D); ADL was assessed using the Health Assessment Questionnaire; and QOL was assessed using the Short Form (SF)-36. Serum OXT levels were determined using enzyme-linked immunosorbent assay. The HAM-D score significantly correlated with the SDAI, and the mental component summary (MCS) score of SF-36. However, the serum OXT levels did not correlate with the HAM-D score. Regression analysis using the HAM-D score as the objective variable identified female sex, smoking, BMI, and all the three component scores of SF-36, but not serum OXT levels, as significant factors. Comparisons between before and after treatment showed that the HAM-D score improved from 5 to 1.5; however, the serum OXT levels did not change. The variables of female sex, smoking, BMI, and QOL correlated with depression complicated with RA. However, serum OXT levels did not correlate directly.</description><identifier>ISSN: 2147-9720</identifier><identifier>EISSN: 2148-4279</identifier><identifier>DOI: 10.5152/eurjrheum.2018.17021</identifier><identifier>PMID: 29657870</identifier><language>eng</language><publisher>Turkey: AVES</publisher><subject>Activities of daily living ; Blood serum ; Complications and side effects ; Depression (Mood disorder) ; Health aspects ; Original ; Oxytocin ; Quality of life ; Rheumatoid arthritis ; Risk factors</subject><ispartof>European journal of rheumatology, 2018-03, Vol.5 (1), p.22-26</ispartof><rights>COPYRIGHT 2018 AVES</rights><rights>Copyright by 2018 Medical Research and Education Association 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0001-5956-7974</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895146/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895146/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29657870$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Miwa, Yusuke</creatorcontrib><creatorcontrib>Furuya, Hidekazu</creatorcontrib><creatorcontrib>Yanai, Ryo</creatorcontrib><creatorcontrib>Kasama, Tsuyoshi</creatorcontrib><creatorcontrib>Sanada, Kenji</creatorcontrib><title>Is the serum oxytocin level altered by treatment in rheumatoid arthritis patients complicated with depression?</title><title>European journal of rheumatology</title><addtitle>Eur J Rheumatol</addtitle><description>The objective of this study was to investigate the factors associated with depression, including serum oxytocin (OXT) levels, disease activity, activities of daily living (ADL), and quality of life (QOL), and their effects on rheumatoid arthritis (RA). This study included 42 RA patients who received treatment with a biological agent. We measured the following variables before and after 6 months of treatment: baseline characteristics, including age, sex, disease duration, smoking, and body mass index (BMI); prednisolone and methotrexate dose; serum level of matrix metalloproteinase-3 (MMP-3); erythrocyte sedimentation rate (ESR); and C-reactive protein (CRP) level. The disease activity of RA was assessed using the Simplified Disease Activity Index (SDAI); depression was assessed using the Hamilton Depression Rating Scale (HAM-D); ADL was assessed using the Health Assessment Questionnaire; and QOL was assessed using the Short Form (SF)-36. Serum OXT levels were determined using enzyme-linked immunosorbent assay. The HAM-D score significantly correlated with the SDAI, and the mental component summary (MCS) score of SF-36. However, the serum OXT levels did not correlate with the HAM-D score. Regression analysis using the HAM-D score as the objective variable identified female sex, smoking, BMI, and all the three component scores of SF-36, but not serum OXT levels, as significant factors. Comparisons between before and after treatment showed that the HAM-D score improved from 5 to 1.5; however, the serum OXT levels did not change. The variables of female sex, smoking, BMI, and QOL correlated with depression complicated with RA. However, serum OXT levels did not correlate directly.</description><subject>Activities of daily living</subject><subject>Blood serum</subject><subject>Complications and side effects</subject><subject>Depression (Mood disorder)</subject><subject>Health aspects</subject><subject>Original</subject><subject>Oxytocin</subject><subject>Quality of life</subject><subject>Rheumatoid arthritis</subject><subject>Risk factors</subject><issn>2147-9720</issn><issn>2148-4279</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNptUstu3CAURVWrJkryB1GF1E03ngI2xmxaRVEfkSJl06wRxpeYCBsXcNr5-zIz6aiRKhYgzuPeCwehS0o2nHL2Edb4GEdYpw0jtNtQQRh9hU4ZbbqqYUK-3p9FJQUjJ-gipUdCCBWMSSreohMmWy46QU7RfJNwHgEniOuEw-9tDsbN2MMTeKx9hggD7rc4R9B5gjnjgu4r6xzcgHXMY3TZJbzo7AqesAnT4p3RuSh_uTziAZYIKbkwfz5Hb6z2CS6e9zN0__XLj-vv1e3dt5vrq9vK1LzJlTaUS4CeW9Zy29i2BUo1G3RPh6GubW_LxFYToQ1osLI3XXkVIhvT1lTUvD5Dnw6-y9pPMJjSWNReLdFNOm5V0E69RGY3qofwpHgnOW3aYvDh2SCGnyukrCaXDHivZwhrUoww3pGG7KnvD9QH7UG52YbiaHZ0dcW5bCVpCSmszX9YZQ0wORNmsK7cvxA0B4GJIaUI9tg9JWoXAnUMgdqFQO1DUGTv_p38KPr75fUfGp-zKg</recordid><startdate>20180301</startdate><enddate>20180301</enddate><creator>Miwa, Yusuke</creator><creator>Furuya, Hidekazu</creator><creator>Yanai, Ryo</creator><creator>Kasama, Tsuyoshi</creator><creator>Sanada, Kenji</creator><general>AVES</general><general>Medical Research and Education Association</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5956-7974</orcidid></search><sort><creationdate>20180301</creationdate><title>Is the serum oxytocin level altered by treatment in rheumatoid arthritis patients complicated with depression?</title><author>Miwa, Yusuke ; Furuya, Hidekazu ; Yanai, Ryo ; Kasama, Tsuyoshi ; Sanada, Kenji</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c354t-ac159eeb5f265f4f66e11a2dab1dd33fbf170fa07aceaef9bc8152094c6317353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Activities of daily living</topic><topic>Blood serum</topic><topic>Complications and side effects</topic><topic>Depression (Mood disorder)</topic><topic>Health aspects</topic><topic>Original</topic><topic>Oxytocin</topic><topic>Quality of life</topic><topic>Rheumatoid arthritis</topic><topic>Risk factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Miwa, Yusuke</creatorcontrib><creatorcontrib>Furuya, Hidekazu</creatorcontrib><creatorcontrib>Yanai, Ryo</creatorcontrib><creatorcontrib>Kasama, Tsuyoshi</creatorcontrib><creatorcontrib>Sanada, Kenji</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>European journal of rheumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Miwa, Yusuke</au><au>Furuya, Hidekazu</au><au>Yanai, Ryo</au><au>Kasama, Tsuyoshi</au><au>Sanada, Kenji</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Is the serum oxytocin level altered by treatment in rheumatoid arthritis patients complicated with depression?</atitle><jtitle>European journal of rheumatology</jtitle><addtitle>Eur J Rheumatol</addtitle><date>2018-03-01</date><risdate>2018</risdate><volume>5</volume><issue>1</issue><spage>22</spage><epage>26</epage><pages>22-26</pages><issn>2147-9720</issn><eissn>2148-4279</eissn><abstract>The objective of this study was to investigate the factors associated with depression, including serum oxytocin (OXT) levels, disease activity, activities of daily living (ADL), and quality of life (QOL), and their effects on rheumatoid arthritis (RA). This study included 42 RA patients who received treatment with a biological agent. We measured the following variables before and after 6 months of treatment: baseline characteristics, including age, sex, disease duration, smoking, and body mass index (BMI); prednisolone and methotrexate dose; serum level of matrix metalloproteinase-3 (MMP-3); erythrocyte sedimentation rate (ESR); and C-reactive protein (CRP) level. The disease activity of RA was assessed using the Simplified Disease Activity Index (SDAI); depression was assessed using the Hamilton Depression Rating Scale (HAM-D); ADL was assessed using the Health Assessment Questionnaire; and QOL was assessed using the Short Form (SF)-36. Serum OXT levels were determined using enzyme-linked immunosorbent assay. The HAM-D score significantly correlated with the SDAI, and the mental component summary (MCS) score of SF-36. However, the serum OXT levels did not correlate with the HAM-D score. Regression analysis using the HAM-D score as the objective variable identified female sex, smoking, BMI, and all the three component scores of SF-36, but not serum OXT levels, as significant factors. Comparisons between before and after treatment showed that the HAM-D score improved from 5 to 1.5; however, the serum OXT levels did not change. The variables of female sex, smoking, BMI, and QOL correlated with depression complicated with RA. However, serum OXT levels did not correlate directly.</abstract><cop>Turkey</cop><pub>AVES</pub><pmid>29657870</pmid><doi>10.5152/eurjrheum.2018.17021</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0001-5956-7974</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2147-9720
ispartof European journal of rheumatology, 2018-03, Vol.5 (1), p.22-26
issn 2147-9720
2148-4279
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5895146
source PubMed Central
subjects Activities of daily living
Blood serum
Complications and side effects
Depression (Mood disorder)
Health aspects
Original
Oxytocin
Quality of life
Rheumatoid arthritis
Risk factors
title Is the serum oxytocin level altered by treatment in rheumatoid arthritis patients complicated with depression?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T06%3A21%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Is%20the%20serum%20oxytocin%20level%20altered%20by%20treatment%20in%20rheumatoid%20arthritis%20patients%20complicated%20with%20depression?&rft.jtitle=European%20journal%20of%20rheumatology&rft.au=Miwa,%20Yusuke&rft.date=2018-03-01&rft.volume=5&rft.issue=1&rft.spage=22&rft.epage=26&rft.pages=22-26&rft.issn=2147-9720&rft.eissn=2148-4279&rft_id=info:doi/10.5152/eurjrheum.2018.17021&rft_dat=%3Cgale_pubme%3EA559690600%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c354t-ac159eeb5f265f4f66e11a2dab1dd33fbf170fa07aceaef9bc8152094c6317353%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2025804046&rft_id=info:pmid/29657870&rft_galeid=A559690600&rfr_iscdi=true